Eteplirsen is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy in patients with a confirmed mutation of the dystrophin gene. This therapeutic agent functions by skipping… Read more
Eteplirsen is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy in patients with a confirmed mutation of the dystrophin gene. This therapeutic agent functions by skipping specific exons during mRNA splicing, thereby facilitating the production of truncated but functional dystrophin protein. To support stringent analytical requirements, this category provides high-quality reference standards, process-related impurities, potential metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for impurity profiling, method validation, and routine quality control to ensure the safety and consistency of the drug substance. By providing characterized standards that accurately mimic the target molecule and its degradation products, these compounds are essential for developing reliable analytical methods and complying with regulatory standards throughout the drug development and manufacturing lifecycle.